Steven Perrin

Insider Reports History

Entity
Individual
Location
C/O Anelixis Therapeutics, Inc., 1500 District Avenue, Burlington, MA
Signature
/s/ Paul Little, as attorney-in-fact for Steve Perrin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Perrin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. President, Director Stock Option (right to buy) 243K $1.3M $1.55 Jan 10, 2025 Direct
Eledon Pharmaceuticals, Inc. President, Director Restricted Stock Units 27K Jan 10, 2025 Direct

Insider Reports Filed by Steven Perrin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELDN Eledon Pharmaceuticals, Inc. Jan 10, 2025 2 $0 4 Jan 13, 2025 President, Director
ELDN Eledon Pharmaceuticals, Inc. Nov 21, 2024 1 $0 4 Nov 22, 2024 President, Director
ELDN Eledon Pharmaceuticals, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 President, Director
ELDN Eledon Pharmaceuticals, Inc. May 1, 2023 1 $0 4 May 2, 2023 President, Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 President, Director
ELDN Eledon Pharmaceuticals, Inc. Nov 23, 2022 1 $2.6K 4 Nov 23, 2022 President, Director
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 President, Director